GLP-1 receptor agonistGLP-1 Agonists
Exenatide
A synthetic version of exendin-4 from Gila monster saliva. FDA-approved as Byetta (twice daily) and Bydureon (weekly). First GLP-1 RA approved for type 2 diabetes (2005). A venom-derived peptide drug.
blood-sugar-controlweight-lossvenom-derivedFDA-approved
3D Structure
3D Structure
4186.57 Da
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A synthetic version of exendin-4 from Gila monster saliva. FDA-approved as Byetta (twice daily) and Bydureon (weekly). First GLP-1 RA approved for type 2 diabetes (2005). A venom-derived peptide drug.